Corneal Tomographic Parameters in TGD
NCT04433936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-06-16
Summary
The current study involved analysis of the corneal tomographic parameters of patients with thyroid gland dysfunction (hyperthyroidism or hypothyroidism), including those with an autoimmune etiology, in comparison to healthy controls without TGD, using pentacam, in an attempt to detect possible early corneal changes and to highlight whether early screening of those patients would be necessary for early detection of KC.
Conditions
- Keratoconus
- Corneal Ectasia
- Thyroid Eye Disease
Interventions
- DIAGNOSTIC_TEST
-
Pentacam tomography
The Pentacam maps were analyzed. The following anterior and posterior corneal surface parameters were evaluated by the Scheimpflug system: Kf, Ks, Kmax. The pachymetric map was analyzed, including CCT at the apex of the geometric center and CTmin. PPIavg, PPI min and PPI max were calculated . The Ambrósio relational thickness (ART) was calculated The posterior corneal elevation maps were evaluated and the posterior corneal elevation values relative to this reference were recorded. The back difference elevation and multimetric D index values were extrapolated from the difference map of the Belin/Ambrósio-enhanced ectasia display of the Pentacam system.
Sponsors & Collaborators
-
Ameera Gamal Abdelhameed
lead OTHER
Principal Investigators
-
Rania Bassiouny, MD · Mansoura University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2018-06-01
- Completion
- 2018-06-01
Countries
- Egypt
Study Locations
More Related Trials
-
Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
NCT03178253 ·Status: UNKNOWN
-
The Impact of Hypothyroidism on Tear Production and Dry Eye Symptoms: Implications for Optometric Care
NCT06913465 ·Status: ACTIVE_NOT_RECRUITING
-
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
NCT06083636 ·Status: RECRUITING
-
A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
NCT07265258 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
NCT06179368 ·Status: RECRUITING
-
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
NCT01801033 ·Status: WITHDRAWN
-
Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections
NCT05429450 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Profiles in Patients With Acute Illness
NCT05980923 ·Status: WITHDRAWN
-
Natural History of Thyroid Function Disorders
NCT00001159 ·Status: RECRUITING
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
NCT07152340 ·Status: RECRUITING ·Phase: PHASE4
-
Serum Thyroid Function After Iodinated Contrast Administration
NCT05786846 ·Status: UNKNOWN
-
Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients
NCT07133295 ·Status: COMPLETED
-
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
NCT01182584 ·Status: UNKNOWN
-
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
NCT01204359 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
NCT07152366 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism
NCT05733078 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
NCT00430547 ·Status: COMPLETED ·Phase: NA
-
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
NCT06275373 ·Status: RECRUITING
-
Esophageal Motility and Gastric Emptying Disorders Among Different Thyroid Dysfunction
NCT07069816 ·Status: NOT_YET_RECRUITING
-
Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
NCT02339142 ·Status: UNKNOWN ·Phase: PHASE4
-
To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
NCT06204393 ·Status: RECRUITING
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA